by Eric Christianson | May 10, 2017 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
When giving a presentation the other day, I received a question about how to handle gabapentin abuse. It is a tough question, much like opioid, benzo, stimulant, or any other controlled substance. Recognizing the risk of abuse potential, in August 2016, Minnesota...
by Eric Christianson | May 7, 2017 | Educational Case Studies For Pharmacists, Neurology, Pain, and Musculoskeletal Case Studies
Here’s a medication list and a few thoughts to go with it. Amiodarone 200 mg daily Famotidine 20 mg daily Enalapril 10 mg daily Metoprolol 25 mg BID Pantoprazole 40 mg daily Acetaminophen 500 mg TID Requip 0.5 mg HS Aranesp (hold for hemoglobin less than 11)...
by Eric Christianson | May 3, 2017 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
So the FDA changed the labeling on metformin a while back and made it a little easier to use the drug in more patients who have poor kidney function. Whenever changes like this happen, I like to take a little time and digest the changes. From a recent Medscape...
by Eric Christianson | Apr 30, 2017 | Cardiovascular Case Studies, Educational Case Studies For Pharmacists
Hypertension management can get a little overwhelming sometimes since there are so many medications to choose from. We often use multiple medications with different mechanisms of action to treat hypertension. If a patient is already on a medication at a moderate or...
by Eric Christianson | Apr 26, 2017 | Educational Case Studies For Pharmacists, Renal, Urology, and Electrolytes Case Studies
Patient reports increasing swelling, sedation, and has complaints of being dizzy. She has been having worsening urinary incontinence which has been classified as stress incontinence. She was recently discontinued off her Enablex as she felt it did not work. ...
